Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
55.17
Dollar change
-0.13
Percentage change
-0.23
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y4.35% Shs Outstand Perf Week-3.16%
SponsorJPMorgan Chase ETF Type Tagsequity Return% 3Y- Total Holdings52 Perf Month-4.13%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM8.30M Perf Quarter-11.90%
Index- Average Maturity Tagsbiotechnology Return% 10Y NAV% Perf Half Y-5.24%
Index Weighting Commodity Type Tagspharmaceutical Return% SI NAV/sh Perf Year6.28%
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range52.05 - 63.49 Perf YTD2.40%
Dividend TTM0.08 (0.14%) ESG Type Tags- Flows% 3M21.26% 52W High-13.11% Beta0.80
Dividend Ex-DateDec 19, 2023 Dividend Type Sector/Theme Flows% YTD-25.30% 52W Low6.00% ATR (14)0.36
Expense0.65% Structure Type Region Flows% 1Y RSI (14)30.46 Volatility0.26% 0.21%
Option/ShortNo / No Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.02 Prev Close55.30
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume0.49K Price55.17
SMA20-2.03% SMA50-4.77% SMA200-5.98% Trades Volume8 Change-0.23%
Jpmorgan Healthcare Leaders ETF seeks to provide long-term capital appreciation. The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.